13F filing recap · Q4 2009
What did Kahn Brothers Group buy in Q4 2009?
Reported stock-position changes between this filing and the previous one.
Stock value
$440.80M
Positions
58
Estimated turnover
14.6%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Increased positions
MRKMerck & Co., Inc.MIXED CORP ACTION$55.22Mreported value+608.1K shares+67.3%BMYBristol-Myers Squibb Company$44.17Mreported value+11.3K shares+0.7%PFEPfizer Inc.$43.71Mreported value+185.1K shares+8.3%NYTThe New York Times Company$12.42Mreported value+73.0K shares+7.8%CCitigroup Inc$8.91Mreported value+393.5K shares+17.1%MEDQMedquist Inc.$5.94Mreported value+59.0K shares+7.1%TRVTravelers Companies, Inc.$4.08Mreported value+445 shares+0.5%ASTEAstec Industries, Inc.$2.56Mreported value+16.0K shares+20.3%CVXChevron Corp$2.50Mreported value+2.2K shares+7.2%IBMInternational Business Machines Corp$2.45Mreported value+800 shares+4.5%XOMExxon Mobil Corp.$1.56Mreported value+3.6K shares+18.8%514928100LANDMARK SAVINGS BANK$1.54Mreported value+4.9K shares+5.0%MONMonsanto Company$957.1Kreported value+304 shares+2.7%BACBank of America Corp$604.6Kreported value+668 shares+1.7%IDTIdt Corp$203.8Kreported value+3.9K shares+10.1%